Brian Gilger

Principal investigator.

Biotech

Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.

2020First federal award

$578KFederal grants as PI2 awards

0Patents grantedNone matched

0PapersOpenAlex

Career record

Federal awards and patents by year

20202021

AwardsPatents

Federal awards as principal investigator

2 awards · $578K

Date	Agency	Award	Amount	Company
Sep 1, 2021	NIH	STTR Phase I Immunosuppressive Gene Therapy for Ocular Graft vs Host Disease	$328K	Bedrock Therapeutics, Inc. with UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
Sep 30, 2020	NIH	STTR Phase I Prevention of corneal transplant rejection using AAV-HLA-G combination therapy	$250K	Bedrock Therapeutics, Inc. with UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL

Among 4,078 researchers in Biotech

Peer ranks

Federal funding#2,303

Awards as PI#1,252

Patents#273

From filings, awards and patents

Companies

Bedrock Therapeutics, Inc.Linked by awards · Biotech

Research partners on awards

Research institutions

University of North Carolina at Chapel Hill

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.